Science wins the grant. Commercial strategy wins the market.
DGB Strategy is a boutique commercialisation consultancy for life science and deep-tech founders. We build the grant narratives, procurement pathways and execution plans that turn breakthrough science into fundable, buyable products.
Grant-ready
Commercial narratives built for competitive funding panels
NHS-fluent
Health-economic framing for real procurement committees
Fractional
CBO-level execution without a full-time hire
Services
Built for grant committees and procurement boards
Three engagement tracks, each aimed at the specific commercial gaps that stall deep-tech and life science ventures between the lab and the market.
Grant Commercial Strategy
Innovate UK, Biomedical Catalyst and Horizon-style applications live or die on the commercial case. We build the market sizing, route-to-revenue and exploitation plan assessors actually score.
- Route-to-market and exploitation narrative
- Credible market sizing and pricing logic
- Panel-ready commercial risk mitigation
NHS & Procurement Readiness
Clinical enthusiasm is not a purchase order. We map the real buyer, the budget line and the evidence they need before you enter a formal procurement process.
- Buyer vs. champion stakeholder mapping
- Health-economic value dossier
- Framework and pathway entry planning
Fractional CBO Engagements
Ongoing commercial leadership embedded with your founding team — owning pipeline, partnerships and the investor-facing commercial story between raises.
- 90-day commercial execution plans
- Partnership and BD pipeline ownership
- Board and investor commercial reporting
How we work
Diagnose, position, execute
01
Diagnose
Run the Commercial Sprint Diagnostic to benchmark readiness, map your GTM archetype and expose the execution gap.
02
Position
Translate scientific mechanism into buyer-facing value: pricing, evidence, and the economic case decision makers fund.
03
Execute
A 90-day commercial roadmap, owned alongside you — grant submissions, procurement entry and partnership conversations.
Benchmark your commercial readiness in 15 minutes
The Commercial Sprint Diagnostic scores your go-to-market readiness, maps your GTM archetype and shows the execution gap investors and assessors will flag — available through accelerator cohorts or as a self-guided purchase.
Go to the diagnostic